Neisseria meningitidis group B correlates of protection and assay standardization -: International meeting report Emory University, Atlanta, Georgia, United States, 16-17 march 2005

被引：161

作者：

Borrow, R.

Carlone, G. M.

Rosenstein, N.

Plikaytis, B.

Blake, M.

Feavers, I.

Martin, D.

Zollinger, W.

Robbins, J.

Aaberge, I.

Granoff, D. M.

Miller, E.

van Alphen, L.

Poolman, J.

Rappuoli, R.

Danzig, L.

Hackell, J.

Danve, B.

Caulfield, M.

Lambert, S.

Stephens, D.

机构：

[1] Manchester Royal Infirm, Vaccine Evaluat Unit, Hlth Protect Agcy, Manchester M13 9WZ, Lancs, England

[2] Ctr Dis Control & Prevent, Atlanta, GA USA

[3] US FDA, Bethesda, MD 20014 USA

[4] Natl Inst Biol Stand & Controls, Potters Bar EN6 3QG, Herts, England

[5] Inst Environm Sci, Porirua, New Zealand

[6] Walter Reed Army Inst Res, Washington, DC USA

[7] NICHHD, NIH, Bethesda, MD 20892 USA

[8] Norwegian Inst Publ Hlth, NO-0403 Oslo, Norway

[9] Childrens Hosp Oakland, Res Inst, Oakland, CA 94660 USA

[10] Hlth Protect Agcy Ctr Infect, London NW9 5EQ, England

[11] Netherlands Vaccine Inst, NL-3720 AL Bilthoven, Netherlands

[12] GlaxoSmithKline Biol, Rixensart, Belgium

[13] Chiron Vaccines, Siena, Italy

[14] Chiron Vaccines, Emeryville, CA 94608 USA

[15] Wyeth Vaccines, Pearl River, NY 10965 USA

[16] Sanofi Pasteur, F-69280 Marcy Letoile, France

[17] Merck & Co Inc, West Point, PA 19486 USA

[18] WHO, CH-1211 Geneva 27, Switzerland

[19] Emory Univ, Dept Med, Atlanta, GA 30322 USA

来源：

VACCINE | 2006年 / 24卷 / 24期

关键词：

D O I：

10.1016/j.vaccine.2006.03.091

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：5093 / 5107

页数：15

共 101 条

[51]

KAIJSER B, 1977, LANCET, V1, P663

[52]

KAYHTY H, 1983, J INFECT DIS, V147, P1100

[53] CLASS-SPECIFIC ANTIBODY-RESPONSE TO GROUP-B NEISSERIA-MENINGITIDIS CAPSULAR POLYSACCHARIDE - USE OF POLYLYSINE PRECOATING IN AN ENZYME-LINKED IMMUNOSORBENT-ASSAY [J].

LEINONEN, M ;

FRASCH, CE .

INFECTION AND IMMUNITY, 1982, 38 (03) :1203-1207

[54] High-throughput imaging of bacterial colonies grown on filter plates with application to serum bactericidal assays [J].

Liu, X ;

Wang, S ;

Sendi, L ;

Caulfield, MJ .

JOURNAL OF IMMUNOLOGICAL METHODS, 2004, 292 (1-2) :187-193

[55]

LUCAS AH, 1995, J IMMUNOL, V154, P4195

[56] Imperfect memory and the development of Haemophilus influenzae type b disease [J].

Lucas, AH ;

Granoff, DM .

PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2001, 20 (03) :235-239

[57]

MAIDEN MC, 2004, 1J INT PATH NEISS C, P4

[58] Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination [J].

Maiden, MCJ ;

Stuart, JM .

LANCET, 2002, 359 (9320) :1829-1830

[59] Validation of the serum bactericidal assay for measurement of functional antibodies against group B meningococci associated with vaccine trials [J].

Martin, D ;

McCallum, L ;

Glennie, A ;

Ruijne, N ;

Blatchford, P ;

O'Hallahan, J ;

Oster, P .

VACCINE, 2005, 23 (17-18) :2218-2221

[60] New Zealand epidemic of meningococcal disease identified by a strain with phenotype B:4:P1.4 [J].

Martin, DR ;

Walker, SJ ;

Baker, MG ;

Lennon, DR .

JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (02) :497-500

← 1 2 3 4 5 6 7 8 9 10 →